Philippe MD - Atreca Chief Officer
| BCELDelisted Stock | USD 0.07 0.0005 0.70% |
Executive
Philippe MD is Chief Officer of Atreca Inc
| Age | 59 |
| Phone | 650 595 2595 |
| Web | https://www.atreca.com |
Atreca Management Efficiency
The company has return on total asset (ROA) of (0.512) % which means that it has lost $0.512 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.827) %, meaning that it created substantial loss on money invested by shareholders. Atreca's management efficiency ratios could be used to measure how well Atreca manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 63.88 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Atreca Inc has a current ratio of 7.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Atreca until it has trouble settling it off, either with new capital or with free cash flow. So, Atreca's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atreca Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atreca to invest in growth at high rates of return. When we think about Atreca's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jan Smith | Revolution Medicines | N/A | |
| Gregory Fuest | Passage Bio | N/A | |
| Karl Whitney | Passage Bio | N/A | |
| Stuart Henderson | Passage Bio | N/A | |
| Kathleen Borthwick | Passage Bio | 47 | |
| Virginia MBA | Alector | N/A | |
| JD Esq | Passage Bio | 60 | |
| Katie Hogan | Alector | N/A | |
| Robert King | Alector | 54 | |
| Norah Conway | Alector | N/A | |
| Xiaolin Wang | Revolution Medicines | 53 | |
| Jonathan JD | Stoke Therapeutics | 34 | |
| Eden Fucci | Passage Bio | N/A | |
| Sue Browne | Passage Bio | N/A | |
| Gary MD | Alector | 62 | |
| Sabah Oney | Alector | 35 | |
| Robert Paul | Alector | 50 | |
| Kristina MPH | Alector | N/A | |
| Erika Jones | Black Diamond Therapeutics | 39 | |
| Danielle JD | Alector | N/A | |
Management Performance
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.51 |
Atreca Inc Leadership Team
Elected by the shareholders, the Atreca's board of directors comprises two types of representatives: Atreca inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atreca. The board's role is to monitor Atreca's management team and ensure that shareholders' interests are well served. Atreca's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atreca's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yann Tan, Chief Technologist | ||
| Herbert Cross, Chief Officer | ||
| Philippe MD, Chief Officer | ||
| Stephen Gould, Chief Officer | ||
| Rick Ruiz, Principal Officer | ||
| Tito Serafini, Founder Director | ||
| John MBA, CEO and Presidentident | ||
| John Orwin, CEO Pres | ||
| Courtney JD, General Secretary | ||
| Roger Ruiz, Vice Finance |
Atreca Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Atreca a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.51 | ||||
| Current Valuation | (17.08 M) | ||||
| Shares Outstanding | 38.41 M | ||||
| Shares Owned By Insiders | 2.73 % | ||||
| Shares Owned By Institutions | 24.54 % | ||||
| Number Of Shares Shorted | 272.73 K | ||||
| Price To Earning | (3.53) X | ||||
| Price To Book | 0.28 X | ||||
| EBITDA | (76.42 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atreca in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atreca's short interest history, or implied volatility extrapolated from Atreca options trading.
Pair Trading with Atreca
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atreca position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will appreciate offsetting losses from the drop in the long position's value.Moving together with Atreca Pink Sheet
| 0.62 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Atreca could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atreca when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atreca - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atreca Inc to buy it.
The correlation of Atreca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atreca moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atreca Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atreca can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |